Clinical outcomes in advanced cervical cancer (CC) and endometrial cancer (EC) patients (pts) treated in phase I trials of novel molecularly targeted agents (MTAs)

Autor:	Mabel Wong, Timothy A. Yap, L Rhoda Molife, Saeed Rafii, Johann S. de Bono, Martin Gore, Rebecca Kristeleit, Tom van Hagen, Angela George, Caroline O. Michie, Susana Banerjee, Grigorios Rallis, Liz Y. Han, Stanley B. Kaye, Rebecca Bowen, Vasiliki Michalarea, Udai Banerji
Rok vydání:	2015
Předmět:	Oncology High rate Gynecology Cervical cancer Cancer Research medicine.medical_specialty business.industry Endometrial cancer Phase i trials medicine.disease Internal medicine Medicine business
Zdroj:	Journal of Clinical Oncology. 33:5596-5596
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2015.33.15_suppl.5596
Popis:	5596 Background: The prognosis for advanced CC and EC pts is poor, with relapse to approved chemotherapies inevitable. In view of the high rate of putative driver mutations, novel MTAs in phase I t...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::3ab931f1defb02ed7eb0921a4022d7a9 https://doi.org/10.1200/jco.2015.33.15_suppl.5596 Zobrazit plný text záznamu